Suppr超能文献

意大利北部新冠肺炎患者肺切除术后的情况。

COVID-19 After Lung Resection in Northern Italy.

机构信息

Thoracic Surgery, ASST Monza, Italy.

Thoracic Surgery, ASST Santi Paolo e Carlo, Milan, Italy.

出版信息

Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):726-732. doi: 10.1053/j.semtcvs.2021.03.038. Epub 2021 May 11.

Abstract

We reviewed surgical cases from 4 Thoracic Surgery departments in the Lombardia region of Italy, the area mostly affected by Coronavirus pandemic in Europe, with the aim to describe the impact of COVID-19 on the treatment of thoracic surgical patients. Clinical, radiological and laboratory data from patients who underwent lung resection from December 2019 to March 2020 were retrospectively collected until June 2020. Univariable Cox regression models were estimated to evaluate potential prognostic factors for developing COVID-19 and to investigate postoperative mortality among patients who developed symptomatic COVID-19 infection. We examined data from 107 patients. (74 lobectomies, 32 wedge/segmentectomies and 1 pneumonectomy). Twelve patients developed COVID-19 (Group 1), whereas 95 patients were not infected (Group 2). In Group 1, 6 patients (50%) died from complications related to infection; in Group 2, one patient (1%) died because of non-COVID-19-related causes. Median days from surgery to first symptoms, CT confirmation, clinical confirmation and PCR positivity was 48.1, 54.3, 55.1, and 55.2 respectively. At univariable analysis, DLCO/VA% (P = 0.008), duration of the surgery (P = 0.009), smoking history (pack/year) (P < 0.001), BMI (P< 0.001) and number of segments resected (P = 0.010) were associated with COVID-19 onset. Moreover, CCI (P < 0.001), DLCO/VA% (P = 0.002), cigarette pack/year (P < 0.001), BMI (P < 0.001) and COVID-19 (P < 0.001) were associated with death. Patients who undergo lung resection and then develop symptomatic COVID-19 infection are at higher risk of developing severe respiratory complications and postoperative death. Insidious symptoms' onset may lead to a delay in diagnosis. We suggest two mitigating strategies: (1) Improve symptoms surveillance and isolation during recovery period, (2) Be aware of a potential greater risk of developing symptomatic COVID-19 and death correlated with elevated CCI, BMI, smoking history, DLCO/VA%, number of resected segments and duration of surgery.

摘要

我们回顾了意大利伦巴第地区 4 个胸外科部门的手术病例,该地区是欧洲冠状病毒大流行的重灾区,目的是描述 COVID-19 对胸外科患者治疗的影响。我们回顾性收集了 2019 年 12 月至 2020 年 3 月期间接受肺切除术的患者的临床、放射学和实验室数据,直至 2020 年 6 月。使用单变量 Cox 回归模型评估了发生 COVID-19 的潜在预后因素,并调查了发生有症状 COVID-19 感染的患者的术后死亡率。我们共检查了 107 名患者的数据(74 例肺叶切除术,32 例楔形切除术/节段切除术和 1 例全肺切除术)。12 名患者发生了 COVID-19(第 1 组),95 名患者未感染(第 2 组)。第 1 组中有 6 名患者(50%)因与感染相关的并发症而死亡;第 2 组中,有 1 名患者(1%)因非 COVID-19 相关原因死亡。从手术到出现首诊症状、CT 确认、临床确认和 PCR 阳性的中位时间分别为 48.1、54.3、55.1 和 55.2 天。单变量分析表明,DLCO/VA%(P=0.008)、手术持续时间(P=0.009)、吸烟史(包/年)(P<0.001)、BMI(P<0.001)和切除的肺段数(P=0.010)与 COVID-19 发病相关。此外,CCI(P<0.001)、DLCO/VA%(P=0.002)、香烟包/年(P<0.001)、BMI(P<0.001)和 COVID-19(P<0.001)与死亡相关。接受肺切除术然后发生有症状 COVID-19 感染的患者发生严重呼吸并发症和术后死亡的风险更高。隐匿性症状的发病可能导致诊断延迟。我们建议采取以下两种缓解策略:(1)改善恢复期的症状监测和隔离;(2)注意与较高的 CCI、BMI、吸烟史、DLCO/VA%、切除的肺段数和手术持续时间相关的发生有症状 COVID-19 和死亡的潜在更大风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f244/8111882/d0967a5dbc83/ga1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验